The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban

Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro

DOI: https://doi.org/10.7175/fe.v15i1s.972

Keywords

Apixaban; Novel oral anticoagulant agents; Atrial fibrillation

Full Text

HTML PDF

References

  • Bollettino Ufficiale della Regione Veneto, 2010. Available at http://bur.regione.veneto.it/BurvServices/pubblica/HomeConsultazione.aspx
  • European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429; http://dx.doi.org/10.1093/eurheartj/ehq278

Statistics

Abstract: 631 views
HTML: 269 views
PDF: 285 views

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.